Effect of cariprazine on metabolic parameters in patients with affective disorders: A systematic review and meta-analysis
Published online on January 21, 2026
Abstract
Journal of Psychopharmacology, Ahead of Print.
Background:Cariprazine is a second-generation antipsychotic approved for treating schizophrenia, acute manic/mixed, and depressive episodes associated with bipolar I disorder, and as adjunctive treatment in major depressive disorder (MDD). Antipsychotic ...
Background:Cariprazine is a second-generation antipsychotic approved for treating schizophrenia, acute manic/mixed, and depressive episodes associated with bipolar I disorder, and as adjunctive treatment in major depressive disorder (MDD). Antipsychotic ...